Neurology Publications

  1. Amann JP, Glauser T, Chiron C. Developing antiepileptic drugs in children: balancing protection and access. Handb Clin Neurol. 2013; 111:741-6.
  2. Amos-Kroohs RM, Williams MT, Braun AA, Graham DL, Webb CL, Birtles TS, Greene RM, Vorhees CV, Pisano MM. Neurobehavioral phenotype of C57BL/6J mice prenatally and neonatally exposed to cigarette smoke. Neurotoxicol Teratol. 2013; 35:34-45.
  3. Arya R, Glauser TA. Pharmacotherapy of focal epilepsy in children: a systematic review of approved agents. CNS Drugs. 2013; 27:273-86.
  4. Arya R, Greiner HM, Lewis A, Mangano FT, Gonsalves C, Holland KD, Glauser TA. Vagus nerve stimulation for medically refractory absence epilepsy. Seizure. 2013; 22:267-70.
  5. Arya R, Mangano FT, Horn PS, Holland KD, Rose DF, Glauser TA. Adverse events related to extraoperative invasive EEG monitoring with subdural grid electrodes: a systematic review and meta-analysis. Epilepsia. 2013; 54:828-39.
  6. Arya R, Shinnar S, Glauser TA. Corticosteroids for the treatment of infantile spasms: a systematic review. J Child Neurol. 2012; 27:1284-8.
  7. Bigras C, Shear PK, Vannest J, Allendorfer JB, Szaflarski JP. The effects of temporal lobe epilepsy on scene encoding. Epilepsy Behav. 2013; 26:11-21.
  8. Buelow JM, Perkins SM, Johnson CS, Byars AW, Fastenau PS, Dunn DW, Austin JK. Adaptive functioning in children with epilepsy and learning problems. J Child Neurol. 2012; 27:1241-9.
  9. Castro OW, Santos VR, Pun RY, McKlveen JM, Batie M, Holland KD, Gardner M, Garcia-Cairasco N, Herman JP, Danzer SC. Impact of corticosterone treatment on spontaneous seizure frequency and epileptiform activity in mice with chronic epilepsy. PLoS One. 2012; 7:e46044.
  10. Chen Y, Curran CP, Nebert DW, Patel KV, Williams MT, Vorhees CV. Effect of chronic glutathione deficiency on the behavioral phenotype of Gclm-/- knockout mice. Neurotoxicol Teratol. 2012; 34:450-7.
  11. Dodge HS, Ekhator NN, Jefferson-Wilson L, Fischer M, Jansen I, Horn PS, Hurford WE, Geracioti TD. Cigarette smokers have reduced risk for post-dural puncture headache. Pain Physician. 2013; 16:E25-30.
  12. Edden RA, Crocetti D, Zhu H, Gilbert DL, Mostofsky SH. Reduced GABA concentration in attention-deficit/hyperactivity disorder. Arch Gen Psychiatry. 2012; 69:750-3.
  13. Elliott I, Kadis DS, Lach L, Olds J, McCleary L, Whiting S, Snyder T, Smith ML. Quality of life in young adults who underwent resective surgery for epilepsy in childhood. Epilepsia. 2012; 53:1577-86.
  14. Epstein LG, Shinnar S, Hesdorffer DC, Nordli DR, Hamidullah A, Benn EK, Pellock JM, Frank LM, Lewis DV, Moshe SL, Shinnar RC, Sun S, team Fs. Human herpesvirus 6 and 7 in febrile status epilepticus: the FEBSTAT study. Epilepsia. 2012; 53:1481-8.
  15. Fisher RS, Blum DE, DiVentura B, Vannest J, Hixson JD, Moss R, Herman ST, Fureman BE, French JA. Seizure diaries for clinical research and practice: limitations and future prospects. Epilepsy Behav. 2012; 24:304-10.
  16. Fletcher S, Adkin CF, Meloni P, Wong B, Muntoni F, Kole R, Fragall C, Greer K, Johnsen R, Wilton SD. Targeted exon skipping to address "leaky" mutations in the dystrophin gene. Mol Ther Nucleic Acids. 2012; 1:e48.
  17. Frank LM, Shinnar S, Hesdorffer DC, Shinnar RC, Pellock JM, Gallentine W, Nordli DR, Jr., Epstein LG, Moshe SL, Lewis DV, Sun S, Team FS. Cerebrospinal fluid findings in children with fever-associated status epilepticus: results of the consequences of prolonged febrile seizures (FEBSTAT) study. J Pediatr. 2012; 161:1169-71.
  18. Franz DN. Everolimus for astrocytomas in tuberous sclerosis - author's reply. Lancet. 2013; 381:1275.
  19. Franz DN, Agricola KD, Tudor CA, Krueger DA. Everolimus for tumor recurrence after surgical resection for subependymal giant cell astrocytoma associated with tuberous sclerosis complex. J Child Neurol. 2013; 28:602-7.
  20. Franz DN, Belousova E, Sparagana S, Bebin EM, Frost M, Kuperman R, Witt O, Kohrman MH, Flamini JR, Wu JY, Curatolo P, de Vries PJ, Whittemore VH, Thiele EA, Ford JP, Shah G, Cauwel H, Lebwohl D, Sahmoud T, Jozwiak S. Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial. Lancet. 2013; 381:125-32.
  21. Fujiwara H, Greiner HM, Lee KH, Holland-Bouley KD, Seo JH, Arthur T, Mangano FT, Leach JL, Rose DF. Resection of ictal high-frequency oscillations leads to favorable surgical outcome in pediatric epilepsy. Epilepsia. 2012; 53:1607-17.
  22. Gilbert DL. Drug Treatments for Tourette Syndrome and Co-Morbid Disorders. In: JT Walkup, JW Mink, KS McNaught, eds. A Family's Guide to Tourette Syndrome. Bloomington, IN: iUniverse Press; 2012:110-124.
  23. Glauser T, Ben-Menachem E, Bourgeois B, Cnaan A, Guerreiro C, Kälviäinen R, Mattson R, French JA, Perucca E, Tomson T, Guidelines ISoA. Updated ILAE evidence review of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia. 2013; 54:551-63.
  24. Glauser TA, Cnaan A, Shinnar S, Hirtz DG, Dlugos D, Masur D, Clark PO, Adamson PC, Childhood Absence Epilepsy Study T. Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy: initial monotherapy outcomes at 12 months. Epilepsia. 2013; 54:141-55.
  25. Glauser TA, Loddenkemper T. Management of childhood epilepsy. Continuum (Minneap Minn). 2013; 19:656-81.
  26. Golekoh MC, Hu S, Norman AM, Horn PS, Brady RC, Wong BL. Comparison of the immunogenicity of intramuscular versus subcutaneous administration of trivalent inactivated influenza vaccine in individuals with neuromuscular diseases. J Child Neurol. 2013; 28:596-601.
  27. Graham DL, Amos-Kroohs RM, Braun AA, Grace CE, Schaefer TL, Skelton MR, Williams MT, Vorhees CV. Neonatal +-methamphetamine exposure in rats alters adult locomotor responses to dopamine D1 and D2 agonists and to a glutamate NMDA receptor antagonist, but not to serotonin agonists. Int J Neuropsychopharmacol. 2013; 16:377-91.
  28. Graham DL, Schaefer TL, Vorhees CV. Neurobehavioral Testing for Developmental Toxicity. In: RD Hood, ed. Developmental and Reproductive Toxicology, A Practical Approach. London: Informa Healthcare; 2012:346-387.
  29. Greiner HM, Horn PS, Holland K, Collins J, Hershey AD, Glauser TA. mRNA blood expression patterns in new-onset idiopathic pediatric epilepsy. Epilepsia. 2013; 54:272-9.
  30. Gummadavelli A, Wang Y, Guo X, Pardos M, Chu H, Liu Y, Horn P, Zhang F, Xiang J. Spatiotemporal and frequency signatures of word recognition in the developing brain: A magnetoencephalographic study. Brain Res. 2013; 1498:20-32.
  31. Guo X, Xiang J, Wang Y, O'Brien H, Kabbouche M, Horn P, Powers SW, Hershey AD. Aberrant neuromagnetic activation in the motor cortex in children with acute migraine: a magnetoencephalography study. PLoS One. 2012; 7:e50095.
  32. Hart CK, Wiley S, Choo DI, Eby C, Tucker L, Schapiro M, Meinzen-Derr J. Developmental disabilities and intracranial abnormalities in children with symptomatic cytomegalovirus and cochlear implants. ISRN Otolaryngol. 2012; 2012:502746.
  33. Hedera P, Xiao J, Puschmann A, Momčilović D, Wu SW, LeDoux MS. Novel PRRT2 mutation in an African-American family with paroxysmal kinesigenic dyskinesia. BMC Neurol. 2012; 12:93.
  34. Hemmerle AM, Dickerson JW, Herring NR, Schaefer TL, Vorhees CV, Williams MT, Seroogy KB. (+/-)3,4-methylenedioxymethamphetamine ("ecstasy") treatment modulates expression of neurotrophins and their receptors in multiple regions of adult rat brain. J Comp Neurol. 2012; 520:2459-74.
  35. Hershey AD. Perimenstrual headache in adolescence. Curr Pain Headache Rep. 2012; 16:474-6.
  36. Hershey AD, Powers SW, Coffey CS, Eklund DD, Chamberlin LA, Korbee LL, Group CS. Childhood and Adolescent Migraine Prevention (CHAMP) study: a double-blinded, placebo-controlled, comparative effectiveness study of amitriptyline, topiramate, and placebo in the prevention of childhood and adolescent migraine. Headache. 2013; 53:799-816.
  37. Hesdorffer DC, Shinnar S, Lewis DV, Moshe SL, Nordli DR, Jr., Pellock JM, MacFall J, Shinnar RC, Masur D, Frank LM, Epstein LG, Litherland C, Seinfeld S, Bello JA, Chan S, Bagiella E, Sun S, team Fs. Design and phenomenology of the FEBSTAT study. Epilepsia. 2012; 53:1471-80.
  38. Holland K, Shinnar S. Status epilepticus in children. Handb Clin Neurol. 2012; 108:795-812.
  39. Jain SV, Horn PS, Simakajornboon N, Glauser TA. Obstructive sleep apnea and primary snoring in children with epilepsy. J Child Neurol. 2013; 28:77-82.
  40. Jain SV, Simakajornboon N, Glauser TA. Provider practices impact adequate diagnosis of sleep disorders in children with epilepsy. J Child Neurol. 2013; 28:589-95.
  41. Korostenskaja M, Harris E, Giovanetti C, Horn P, Wang Y, Rose D, Fujiwara H, Xiang J. Magnetoencephalography reveals altered auditory information processing in youth with obsessive-compulsive disorder. Psychiatry Res. 2013; 212:132-40.
  42. Krueger DA, Care MM, Agricola K, Tudor C, Mays M, Franz DN. Everolimus long-term safety and efficacy in subependymal giant cell astrocytoma. Neurology. 2013; 80:574-80.
  43. Lebowitz ER, Motlagh MG, Katsovich L, King RA, Lombroso PJ, Grantz H, Lin H, Bentley MJ, Gilbert DL, Singer HS, Coffey BJ, Tourette Syndrome Study G, Kurlan RM, Leckman JF. Tourette syndrome in youth with and without obsessive compulsive disorder and attention deficit hyperactivity disorder. Eur Child Adolesc Psychiatry. 2012; 21:451-7.
  44. Malinowska IA, Lee N, Kumar V, Thiele EA, Franz DN, Ashwal S, Sagalowsky A, Dimario FJ, Jr., Cutler D, Krueger D, Camposano S, Paolini J, Dabora SL. Similar trends in serum VEGF-D levels and kidney angiomyolipoma responses with longer duration sirolimus treatment in adults with tuberous sclerosis. PLoS One. 2013; 8:e56199.
  45. Miles L, Miles MV, Horn PS, Degrauw TJ, Wong BL, Bove KE. Importance of muscle light microscopic mitochondrial subsarcolemmal aggregates in the diagnosis of respiratory chain deficiency. Hum Pathol. 2012; 43:1249-57.
  46. Modi AC, Ingerski LM, Rausch JR, Glauser TA, Drotar D. White coat adherence over the first year of therapy in pediatric epilepsy. J Pediatr. 2012; 161:695-9 e1.
  47. Modi AC, Wu YP, Guilfoyle SM, Glauser TA. Uninformed clinical decisions resulting from lack of adherence assessment in children with new-onset epilepsy. Epilepsy Behav. 2012; 25:481-4.
  48. Morita DA, Glauser TA, Modi AC. Development and validation of the Pediatric Epilepsy Side Effects Questionnaire. Neurology. 2012; 79:1252-8.
  49. Morrison JA, Glueck CJ, Daniels SR, Horn PS, Wang P. Determinants of ApoB, ApoA1, and the ApoB/ApoA1 ratio in healthy schoolgirls, prospectively studied from mean ages 10 to 19 years: the Cincinnati National Growth and Health Study. Metabolism. 2012; 61:1377-87.
  50. Namasivayam AK, Pukonen M, Goshulak D, Yu VY, Kadis DS, Kroll R, Pang EW, De Nil LF. Relationship between speech motor control and speech intelligibility in children with speech sound disorders. J Commun Disord. 2013; 46:264-80.
  51. Natarajan N, Jain SV, Chaudhry H, Hallinan BE, Simakajornboon N. Narcolepsy-cataplexy: is streptococcal infection a trigger?. J Clin Sleep Med. 2013; 9:269-70.
  52. Ngamprasertwong P, Michelfelder EC, Arbabi S, Choi YS, Statile C, Ding L, Boat A, Eghtesady P, Holland K, Sadhasivam S. Anesthetic techniques for fetal surgery: effects of maternal anesthesia on intraoperative fetal outcomes in a sheep model. Anesthesiology. 2013; 118:796-808.
  53. Okun MS, Foote KD, Wu SS, Ward HE, Bowers D, Rodriguez RL, Malaty IA, Goodman WK, Gilbert DM, Walker HC, Mink JW, Merritt S, Morishita T, Sanchez JC. A trial of scheduled deep brain stimulation for Tourette syndrome: moving away from continuous deep brain stimulation paradigms. JAMA Neurol. 2013; 70:85-94.
  54. Pestian J, Matykiewicz P, Holland-Bouley K, Standridge S, Spencer M, Glauser T. Selecting anti-epileptic drugs: a pediatric epileptologist's view, a computer's view. Acta Neurol Scand. 2013; 127:208-15.
  55. Pun RY, Rolle IJ, Lasarge CL, Hosford BE, Rosen JM, Uhl JD, Schmeltzer SN, Faulkner C, Bronson SL, Murphy BL, Richards DA, Holland KD, Danzer SC. Excessive activation of mTOR in postnatally generated granule cells is sufficient to cause epilepsy. Neuron. 2012; 75:1022-34.
  56. Richtand NM, Ahlbrand R, Horn PS, Chambers B, Davis J, Benoit S. Effects of prenatal immune activation and peri-adolescent stress on amphetamine-induced conditioned place preference in the rat. Psychopharmacology (Berl). 2012; 222:313-24.
  57. Riviello JJ, Jr., Claassen J, LaRoche SM, Sperling MR, Alldredge B, Bleck TP, Glauser T, Shutter L, Treiman DM, Vespa PM, Bell R, Brophy GM, Neurocritical Care Society Status Epilepticus Guideline Writing C. Treatment of status epilepticus: an international survey of experts. Neurocrit Care. 2013; 18:193-200.
  58. Roenker NL, Gudelsky GA, Ahlbrand R, Horn PS, Richtand NM. Evidence for involvement of nitric oxide and GABA(B) receptors in MK-801- stimulated release of glutamate in rat prefrontal cortex. Neuropharmacology. 2012; 63:575-81.
  59. Rose DF, Fujiwara H, Holland-Bouley K, Greiner HM, Arthur T, Mangano FT. Focal Peak Activities in Spread of Interictal-Ictal Discharges in Epilepsy with Beamformer MEG: Evidence for an Epileptic Network?. Front Neurol. 2013; 4:56.
  60. Rutter MM, Collins J, Rose SR, Woo JG, Sucharew H, Sawnani H, Hor KN, Cripe LH, Wong BL. Growth hormone treatment in boys with Duchenne muscular dystrophy and glucocorticoid-induced growth failure. Neuromuscul Disord. 2012; 22:1046-56.
  61. Schaefer TL, Braun AA, Amos-Kroohs RM, Williams MT, Ostertag E, Vorhees CV. A new model of Pde4d deficiency: genetic knock-down of PDE4D enzyme in rats produces an antidepressant phenotype without spatial cognitive effects. Genes Brain Behav. 2012; 11:614-22.
  62. Scharf JM, Yu D, Mathews CA, Neale BM, Stewart SE, Fagerness JA, Evans P, Gamazon E, Edlund CK, Service SK, Tikhomirov A, Osiecki L, Illmann C, Pluzhnikov A, Konkashbaev A, Davis LK, Han B, Crane J, Moorjani P, Crenshaw AT, Parkin MA, Reus VI, Lowe TL, Rangel-Lugo M, Chouinard S, Dion Y, Girard S, Cath DC, Smit JH, King RA, Fernandez TV, Leckman JF, Kidd KK, Kidd JR, Pakstis AJ, State MW, Herrera LD, Romero R, Fournier E, Sandor P, Barr CL, Phan N, Gross-Tsur V, Benarroch F, Pollak Y, Budman CL, Bruun RD, Erenberg G, Naarden AL, Lee PC, Weiss N, Kremeyer B, Berrio GB, Campbell DD, Cardona Silgado JC, Ochoa WC, Mesa Restrepo SC, Muller H, Valencia Duarte AV, Lyon GJ, Leppert M, Morgan J, Weiss R, Grados MA, Anderson K, Davarya S, Singer H, Walkup J, Jankovic J, Tischfield JA, Heiman GA, Gilbert DL, Hoekstra PJ, Robertson MM, Kurlan R, Liu C, Gibbs JR, Singleton A, North American Brain Expression C, Hardy J, Database UKHBE, Strengman E, Ophoff RA, Wagner M, Moessner R, Mirel DB, Posthuma D, Sabatti C, Eskin E, Conti DV, Knowles JA, Ruiz-Linares A, Rouleau GA, Purcell S, Heutink P, Oostra BA, McMahon WM, Freimer NB, Cox NJ, Pauls DL. Genome-wide association study of Tourette's syndrome. Mol Psychiatry. 2013; 18:721-8.
  63. Sethi NK, Tenney JR. Child Neurology: Hemiconvulsion-hemiplegia-epilepsy syndrome. Neurology. 2012; 79:2367; author reply 2367-8.
  64. Shinnar S, Glauser T. Commentary on Anticonvulsant Screening Program update: children are not little adults. Epilepsia. 2012; 53:1843-4.
  65. Siegel M, Allendorfer JB, Lindsell CJ, Vannest J, Szaflarski JP. The effects of linguistic relationships among paired associates on verbal self-generation and recognition memory. Brain Behav. 2012; 2:789-95.
  66. Slater SK, Kashikar-Zuck SM, Allen JR, LeCates SL, Kabbouche MA, O'Brien HL, Hershey AD, Powers SW. Psychiatric comorbidity in pediatric chronic daily headache. Cephalalgia. 2012; 32:1116-22.
  67. Stacpoole PW, deGrauw TJ, Feigenbaum AS, Hoppel C, Kerr DS, McCandless SE, Miles MV, Robinson BH, Tang PH. Design and implementation of the first randomized controlled trial of coenzyme CoQ₁₀ in children with primary mitochondrial diseases. Mitochondrion. 2012; 12:623-9.
  68. Standridge SM, Horn PS. Variations in hospitalization outcomes in children admitted with seizures between 2003 and 2006. J Child Neurol. 2012; 27:898-906.
  69. Sun Y, Zamzow M, Ran H, Zhang W, Quinn B, Barnes S, Witte DP, Setchell KD, Williams MT, Vorhees CV, Grabowski GA. Tissue-specific effects of saposin A and saposin B on glycosphingolipid degradation in mutant mice. Hum Mol Genet. 2013; 22:2435-50.
  70. Szaflarski JP, Allendorfer JB, Banks C, Vannest J, Holland SK. Recovered vs. not-recovered from post-stroke aphasia: The contributions from the dominant and non-dominant hemispheres. Restor Neurol Neurosci. 2013; 31:347-60.
  71. Tate ED, Pranzatelli MR, Verhulst SJ, Markwell SJ, Franz DN, Graf WD, Joseph SA, Khakoo YN, Lo WD, Mitchell WG, Sivaswamy L. Active comparator-controlled, rater-blinded study of corticotropin-based immunotherapies for opsoclonus-myoclonus syndrome. J Child Neurol. 2012; 27:875-84.
  72. Tenney JR, Glauser TA. The current state of absence epilepsy: can we have your attention?. Epilepsy Curr. 2013; 13:135-40.
  73. Tenney JR, Schapiro MB. Child neurology: hemiconvulsion-hemiplegia-epilepsy syndrome. Neurology. 2012; 79:e1-4.
  74. Uzark K, King E, Cripe L, Spicer R, Sage J, Kinnett K, Wong B, Pratt J, Varni JW. Health-related quality of life in children and adolescents with Duchenne muscular dystrophy. Pediatrics. 2012; 130:e1559-66.
  75. Vannest J, Szaflarski JP, Eaton KP, Henkel DM, Morita D, Glauser TA, Byars AW, Patel K, Holland SK. Functional magnetic resonance imaging reveals changes in language localization in children with benign childhood epilepsy with centrotemporal spikes. J Child Neurol. 2013; 28:435-45.
  76. Vorhees CV, Graham DL, Braun AA, Schaefer TL, Skelton MR, Richtand NM, Williams MT. Prenatal immune challenge in rats: altered responses to dopaminergic and glutamatergic agents, prepulse inhibition of acoustic startle, and reduced route-based learning as a function of maternal body weight gain after prenatal exposure to poly IC. Synapse. 2012; 66:725-37.
  77. Wang Y, Adamson C, Yuan W, Altaye M, Rajagopal A, Byars AW, Holland SK. Sex differences in white matter development during adolescence: a DTI study. Brain Res. 2012; 1478:1-15.
  78. Winawer MR, Connors R, Investigators E. Evidence for a shared genetic susceptibility to migraine and epilepsy. Epilepsia. 2013; 54:288-95.
  79. Wu SW, Gilbert DL. Gilles de la Tourette Syndrome. In: ET Bope, R Kellerman, eds. Conn's Current Therapy. Philadelphia, PA: Oxford/Saunders; 2013:605-607.
  80. Wu SW, Gilbert DL. Altered neurophysiologic response to intermittent theta burst stimulation in Tourette syndrome. Brain Stimul. 2012; 5:315-9.
  81. Wu SW, Gilbert DL, Shahana N, Huddleston DA, Mostofsky SH. Transcranial magnetic stimulation measures in attention-deficit/hyperactivity disorder. Pediatr Neurol. 2012; 47:177-85.
  82. Wu SW, Shahana N, Huddleston DA, Gilbert DL. Effects of 30Hz theta burst transcranial magnetic stimulation on the primary motor cortex. J Neurosci Methods. 2012; 208:161-4.
  83. Wu SW, Shahana N, Huddleston DA, Lewis AN, Gilbert DL. Safety and tolerability of theta-burst transcranial magnetic stimulation in children. Dev Med Child Neurol. 2012; 54:636-9.